GLP-1 Medications for PCOS: What the Research Actually Shows

If you have PCOS, you’ve probably heard GLP-1 medications mentioned as a weight and insulin-resistance option — and also seen a lot of overclaiming online. Here’s the honest, sourced version: what the research actually supports, what’s still uncertain, and the one safety point that matters most if you might want to get pregnant.

First, the status: off-label

No GLP-1 is FDA-approved specifically to treat PCOS. Semaglutide (Wegovy/Ozempic), liraglutide, and tirzepatide (Zepbound/Mounjaro) are approved for weight management or type 2 diabetes — not PCOS. The 2023 International PCOS Guideline states plainly that medical therapy is generally not approved specifically for PCOS, so any use here is off-label (Teede et al., JCEM 2023). In practice, people with PCOS are usually prescribed a GLP-1 against an approved indication they do meet — most often the obesity/overweight criteria (BMI ≥30, or ≥27 with a weight-related condition), or type 2 diabetes.

What the research supports

Because PCOS is closely tied to weight and insulin resistance, this is where GLP-1s look genuinely useful. A meta-analysis of 13 randomized controlled trials in women with PCOS found, versus metformin or placebo (meta-analysis, 2024):

• Body weight: about 3.6 kg greater reduction on average.
• Insulin resistance (HOMA-IR): a significant improvement.
• BMI: a significant reduction.

Those metabolic effects are the strongest, most consistent findings.

What’s mixed or uncertain (the honest part)

• Androgens / testosterone: genuinely mixed. The pooled randomized-trial analysis above found no significant change in total testosterone, while other reviews report modest reductions in free testosterone (largely via weight loss and rising SHBG). So it’s fair to say GLP-1s reliably help weight and insulin resistance, but you shouldn’t rely on them as an androgen-lowering treatment.
• Menstrual cycles / ovulation / fertility: there are signals that cycles can become more regular — but this appears driven mainly by weight loss, and high-quality trials with menstrual or ovulation endpoints are lacking. Treat the eye-catching fertility statistics you see online as small, early studies, not established efficacy. GLP-1s are not fertility drugs.

GLP-1 vs metformin

They’re different tools, not a simple “which wins.” Metformin actually carries a stronger recommendation in the 2023 guideline (for BMI ≥25), while GLP-1s are a conditional option added to lifestyle change. GLP-1s tend to drive more weight and insulin-resistance improvement, and some research suggests metformin + a GLP-1 together beats metformin alone. Which path fits you depends on your goals, BMI, cost, tolerance — and whether pregnancy is on the horizon.

⚠️ The pregnancy caution — read this if conception is possible

This is the most important part of the whole article. GLP-1s are not recommended in pregnancy. The FDA label for semaglutide says to stop it at least 2 months before you plan to become pregnant, because the drug has a long half-life and takes weeks to clear (FDA Wegovy label). The 2023 PCOS guideline reinforces this: use effective contraception while on a GLP-1, since pregnancy safety data are lacking.

The irony worth naming: many people with PCOS are pursuing weight loss partly for fertility — and GLP-1s and active conception don’t mix. If getting pregnant soon is the goal, a GLP-1 generally isn’t the right tool for that window. This is a conversation to have explicitly with your clinician before starting. (The 2-month figure is specific to semaglutide’s long half-life; other medications differ — ask about yours.)

The bottom line

For PCOS, GLP-1s have a real, evidence-backed role in weight and insulin resistance, a mixed picture on androgens, and a promising-but-unproven one on cycles and fertility — all off-label, alongside (not instead of) lifestyle, and with a firm pregnancy caution. The 2023 guideline treats them as a reasonable conditional option for higher weight in PCOS, with metformin still the stronger first-line for many.

If you’re weighing this, the useful next steps are a real conversation with a clinician who knows your history, and — if you don’t have a prescriber — our guide to getting a GLP-1 prescription online and our honest provider comparison. Protecting muscle while you lose weight matters here too; see what the research says on muscle loss and our free protein calculator.

Educational content, not medical advice. PCOS management is individual, GLP-1 use in PCOS is off-label, and the pregnancy cautions above are important — only a licensed clinician who knows your history can advise whether a GLP-1 is appropriate for you, and if you are pregnant, trying to conceive, or breastfeeding. Research and drug labels change; verify current details with your prescriber.